Circle Pharma
Li-Fen received her B.S. in Clinical Nutrition from Chun-Shan Medical School in Taiwan and earned her Ph.D. in Molecular Biology and Human Nutrition from the Ohio State University. As a postdoctoral research fellow at the endocrinology division of the school of medicine at Stanford University, Li-Fen investigated the role of adapt immunity in insulin resistance and inflammation in humans. Li-Fen previously worked as a senior scientific researcher at OBD/Genentech, where she supported biomarker discovery and evaluation for anti-PDL1 programs, focusing on Reverse Translation projects and academic collaborations to further the understanding of resistance mechanisms to anti-PD-L1 in Renal Cell Carcinoma. Prior to joining Circle, Li-Fen held a position as a Senior Data Analytics Manager on the Translational Medicine team supervised by Evelyn Wang at Exelixis. She is incredibly excited to leverage her understanding of tumor metabolism and programming skills to develop potential drug targets that address unmet needs in the oncology space. In her free time, Li-Fen also enjoys hiking, gardening, bird watching, and Zumba dance.
This person is not in any offices
Circle Pharma
2 followers
Circle Pharma, Inc. initiated operations in June 2014 with seed funding from Pfizer, Inc. and Mission Bay Capital, LLP; we received additional seed funding from ShangPharma Investment Group Limited in November 2015. We recently raised Series B and Series C financing from The Column Group and NextTech Invest.